These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24241267)

  • 1. Factors associated with time-to-treatment of prostate cancer in Florida.
    Xiao H; Tan F; Goovaerts P; Adunlin G; Ali A; Huang Y; Gwede CK
    J Health Care Poor Underserved; 2013 Nov; 24(4 Suppl):132-46. PubMed ID: 24241267
    [No Abstract]   [Full Text] [Related]  

  • 2. Geographical, temporal and racial disparities in late-stage prostate cancer incidence across Florida: a multiscale joinpoint regression analysis.
    Goovaerts P; Xiao H
    Int J Health Geogr; 2011 Dec; 10():63. PubMed ID: 22142274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Comorbidities on Prostate Cancer Stage at Diagnosis in Florida.
    Xiao H; Tan F; Goovaerts P; Adunlin G; Ali AA; Gwede CK; Huang Y
    Am J Mens Health; 2016 Jul; 10(4):285-95. PubMed ID: 25542838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasectomy and prostate cancer in US blacks and whites.
    Hayes RB; Pottern LM; Greenberg R; Schoenberg J; Swanson GM; Liff J; Schwartz AG; Brown LM; Hoover RN
    Am J Epidemiol; 1993 Feb; 137(3):263-9. PubMed ID: 8452134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial Disparity in Time Between First Diagnosis and Initial Treatment of Prostate Cancer.
    Kinlock BL; Thorpe RJ; Howard DL; Bowie JV; Ross LE; Fakunle DO; LaVeist TA
    Cancer Control; 2016 Jan; 23(1):47-51. PubMed ID: 27009456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut.
    Polednak AP; Flannery JT
    Cancer; 1992 Oct; 70(8):2152-8. PubMed ID: 1394045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
    Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
    JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer.
    Anderson DW
    Ethn Dis; 2002; 12(1):S2-63-5. PubMed ID: 11913649
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: racial/ethnic disparities in the treatment of localized/regional prostate cancer.
    Denberg TD
    J Urol; 2004 Oct; 172(4 Pt 1):1547-8; author reply 1548. PubMed ID: 15371898
    [No Abstract]   [Full Text] [Related]  

  • 10. Progress in the control of prostate cancer, Rhode Island, 1987-1998.
    Fulton JP
    Med Health R I; 2001 Mar; 84(3):100-1. PubMed ID: 11280130
    [No Abstract]   [Full Text] [Related]  

  • 11. Why is the prostate cancer death rate declining in the United States?
    Mettlin CJ; Murphy GP
    Cancer; 1998 Jan; 82(2):249-51. PubMed ID: 9445178
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostate cancer in Illinois.
    Guinan PD; Wiggishoff CC; Rotkin ID; Chmiel JS; Sylvester J; Cunningham MP
    IMJ Ill Med J; 1984 Nov; 166(5):341-5. PubMed ID: 6150912
    [No Abstract]   [Full Text] [Related]  

  • 13. Hospital racial composition and the treatment of localized prostate cancer.
    Pollack CE; Bekelman JE; Liao KJ; Armstrong K
    Cancer; 2011 Dec; 117(24):5569-78. PubMed ID: 21692067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race and the likelihood of localized prostate cancer at diagnosis among men in 4 southeastern states.
    Oliver MN; Stukenborg GJ
    J Natl Med Assoc; 2009 Aug; 101(8):750-7. PubMed ID: 19715036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing incidence of cancer of the prostate. The experience of black and white men in the Detroit metropolitan area.
    Demers RY; Swanson GM; Weiss LK; Kau TY
    Arch Intern Med; 1994 Jun; 154(11):1211-6. PubMed ID: 8203988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argument for prostate cancer screening in populations of African-Caribbean origin.
    Patrick AL; Bunker CH; Nelson JB; Dhir R; Wheeler VW; Zmuda JM; Richard JR; Belle AC; Kuller LH
    BJU Int; 2015 Oct; 116(4):507-8. PubMed ID: 25046681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The National Cancer Data Base report on prostate cancer.
    Mettlin CJ; Murphy G
    Cancer; 1994 Sep; 74(5):1640-8. PubMed ID: 8062197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of prostate cancer incidence using geographic information system and multilevel modeling.
    Xiao H; Gwede CK; Kiros G; Milla K
    J Natl Med Assoc; 2007 Mar; 99(3):218-25. PubMed ID: 17393945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the treatment of localized prostate cancer using supplemented cancer registry data.
    Hamilton AS; Albertsen PC; Johnson TK; Hoffman R; Morrell D; Deapen D; Penson DF
    BJU Int; 2011 Feb; 107(4):576-84. PubMed ID: 20735387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of prostate cancer with PSA: the Washington University experience.
    Smith DS
    Can J Oncol; 1994 Nov; 4 Suppl 1():57-62. PubMed ID: 8853491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.